Lonza is expanding its microbial manufacturing facility in Visp, Switzerland. The new facility will provide mid-scale commercial manufacturing to multiple customers and in particular, serve the growing needs of Servier, an independent international pharmaceutical company and long-term Lonza partner.   Servier and Lonza have recently signed a long-term extension to the manufacturing agreement for L-asparaginase, produced at Lonza since 2009. The extension and expansion of the collaboration will...